Short Interest in Kissei Pharmaceutical Co., Ltd. (OTCMKTS:KSPHF) Increases By 32.1%

Kissei Pharmaceutical Co., Ltd. (OTCMKTS:KSPHF) was the recipient of a large growth in short interest during the month of August. As of August 31st, there was short interest totalling 3,700 shares, a growth of 32.1% from the August 15th total of 2,800 shares. Based on an average daily trading volume, of 0 shares, the short-interest ratio is presently ∞ days.

Kissei Pharmaceutical Stock Performance

Shares of KSPHF stock remained flat at $21.48 on Monday. The firm’s 50-day moving average is $20.70 and its 200-day moving average is $21.56. Kissei Pharmaceutical has a fifty-two week low of $19.32 and a fifty-two week high of $21.48.

About Kissei Pharmaceutical

Kissei Pharmaceutical Co, Ltd. researches, develops, manufactures, and sells pharmaceutical products primarily in Japan. The company offers Kalogra tablets, for the treatment of ulcerative colitis; Tabuneos capsules for the treatment of microscopic polyangiitis and granulomatous polyangiitis; Minirin Melt OD tablets; Malizeb tablets; Tavaris tablets for the treatment of chronic idiopathic thrombocytopenic purpura; Beova tablets for the treatment of overactive bladder treatment; and Darbepoetin Alfa BS injection JCR for the treatment of renal anemia.